*requires Macromedia Flash Player
- Using circulating tumor DNA (ctDNA) for the early detection of cancer.
The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold new approach for the early detection of cancer. The approach is based on the detection of small amounts of DNA released by small cancers into the blood stream. It is our hope that this approach will allow clinicians to detect small curable cancers. This test is currently under development and is not available clinically at this time. This test is currently under development and is not available clinically at this time.
- Pancreatic Cancer Sequencing Project
(Wenjing Wu's 2012 Thesis Project)
- Visualizing Nonsense Mediated Decay Inhibition for the Treatment of PC
(An education animation by Jon Geganto)
- New Information About The Early Precursors to Pancreatic Cancer
(An education animation by Lauren O'Malley)
- Pancreas Cysts: 5 helpful hits for diagnosis
(An educational cyst comparison tool)
- Nanotechnology and Pancreatic Cancer
(An educational animation by Leslie Leonard, M.A.)
- Mouse Model for Pancreatic Cancer
(An educational animation by Christian Rose, M.A)
- Pancreatic Cancer Vaccine
(An educational animation by Helen MacFarlane, M.A.)
Dr. Ralph Hruban, Director of the Sol Goldman Pancreatic Cancer research Center here at Johns Hopkins was recently interviewed on ReachMD XM 157, an XM radio station for medical professionals. In a series of three interviews Dr. Hruban discussed the current state of our understanding of pancreatic cancer. Although these interviews are geared towards medical professionals, we thought you might find them educational.
Dr. Joseph Herman was also interviewed on XM radio, where he discussed some treatment options and the Multi-Disciplinary Pancreatic Cancer Clinic at Johns Hopkins.